Cargando…

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema

Objective: This study aimed to analyze the variation in subfoveal choroidal thickness (SFCT) and its relationship with the variation in central macular thickness (CME) in response to intravitreal therapy with an antiangiogenic (anti-VEGF) drug or corticosteroid in type 2 diabetic patients with diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udaondo Mirete, Patricia, Muñoz-Morata, Carmen, Albarrán-Diego, César, España-Gregori, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821174/ https://www.ncbi.nlm.nih.gov/pubmed/36615148 http://dx.doi.org/10.3390/jcm12010348

Ejemplares similares

CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA
por: Moon, Ka Young, et al.
Publicado: (2021)

Subfoveal choroidal thickness in diabetic macular edema
por: Mohamed, Dalia Mohamed Fawzy, et al.
Publicado: (2019)

Choroidal Thickness in Different Patterns of Diabetic Macular Edema
por: Amjad, Rida, et al.
Publicado: (2022)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Early Retinal and Choroidal Coat Thickness Changes after Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema
por: Horozoğlu, Fatih, et al.
Publicado: (2018)

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor
por: Savur, Fatma, et al.
Publicado: (2022)

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study
por: Rishi, Pukhraj, et al.
Publicado: (2021)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat, Alaa, et al.
Publicado: (2021)

Relationship between diabetic macular edema and choroidal layer thickness
por: Endo, Hiroaki, et al.
Publicado: (2020)

Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion
por: Aljundi, Wissam, et al.
Publicado: (2023)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2011)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)

Choroidal Thickness Measurements in the Case of Diabetic Macular Edema. Comment on Amjad et al. Choroidal Thickness in Different Patterns of Diabetic Macular Edema. J. Clin. Med. 2022, 11, 6169
por: Marino, Andrea Valerio, et al.
Publicado: (2023)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq, Bushra, et al.
Publicado: (2014)

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy
por: He, Lingmin, et al.
Publicado: (2011)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020)

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
por: Nishide, Tadayuki, et al.
Publicado: (2013)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema
por: Bilici, Serdar, et al.
Publicado: (2023)

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
por: Sharma, Ashish, et al.
Publicado: (2012)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
por: Bae, Ki Woong, et al.
Publicado: (2022)

Full thickness macular hole following intravitreal ranibizumab injection for diabetic macular edema; a rare complication or coincidence?
por: Arifoglu, Hasan Basri, et al.
Publicado: (2015)

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013)

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes
por: Moradian, Siamak, et al.
Publicado: (2023)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh, Dominic, et al.
Publicado: (2011)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2006)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim, Moosang, et al.
Publicado: (2013)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
por: Kiire, Christine A, et al.
Publicado: (2015)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
por: Klein, Kendra A., et al.
Publicado: (2017)

Reply to Marino et al. Choroidal Thickness Measurements in the Case of Diabetic Macular Edema. Comment on “Amjad et al. Choroidal Thickness in Different Patterns of Diabetic Macular Edema. J. Clin. Med. 2022, 11, 6169”
por: Amjad, Rida, et al.
Publicado: (2023)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8lp71qglj2timjgctcg1k41vd3